Yasuhisa Fujii

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.

Hisashi Hidaka, Yasuharu Sasaki, Toshio Tanaka et al. · Proceedings of the National Academy of Sciences · 1981 · 586 citations · Full text

Life Sciences, Cell Biology, Pharmacology +15

Distilling Step-by-Step! Outperforming Larger Language Models with Less Training Data and Smaller Model Sizes

Cheng-Yu Hsieh, Chunliang Li, Chih‐Kuan Yeh et al. · 2023 · 250 citations · Full text

Computing, Computer Science, Computational Linguistics +8

Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry

Yoshinobu Komai, Mutsunori Fujiwara, Yasuhisa Fujii et al. · Clinical Cancer Research · 2009 · 237 citations

Medicine, Oncology, Genitourinary Oncology +13

The G/G Genotype of a Resistin Single-Nucleotide Polymorphism at −420 Increases Type 2 Diabetes Mellitus Susceptibility by Inducing Promoter Activity through Specific Binding of Sp1/3

Haruhiko Osawa, Kazuya Yamada, Hiroshi Onuma et al. · The American Journal of Human Genetics · 2004 · 233 citations · Full text

Medicine, Genetics, Molecular Genetics +15